Face shields might be more useful than face masks for protecting the public from COVID-19Iowa researchers outline potential advantages of using face shields as an alternative to face masks in the community Could remdesivir be a game changer for COVID patients? Experts say wait for dataOne U.S. study found recovery in patients using the drug was shortened by 31%—11 days on average versus 15 days for those just given usual care New series of videos on COVID-19: What Pharmacists Know Now The BC Branch of the Canadian Society of Hospital Pharmacists releases educational videos on COVID-19 Canadian interim guidelines for managing patients with moderate to severe COVID-19 Provide advice on timely, effective and safe supportive management of adults and children with suspected or confirmed COVID-19 Gilead seeks Health Canada approval for HIV PrEP indication for Descovy Submission based on data from the DISCOVER trial, which compared Descovy to Truvada Pharmacologic treatments under study for COVID-19 No proven effective therapies currently exist for COVID-19 prophylaxis or treatment, but numerous agents are being examined in clinical trials Suspect COVID-19 in patients presenting with neurological symptoms Neurological manifestations may include impaired consciousness, stroke, ataxia, seizure, taste/smell impairment, vision impairment, nerve pain and skeletal muscle pain Five specific steps to help ease COVID-19 anxiety among frontline healthcare professionals Above all, express genuine gratitude for healthcare professionals’ commitment to caring for patients with COVID-19 Researchers to study whether plasma of recovered patients can treat COVID-19 Researchers from across Canada will collaborate on a vast clinical trial to study whether the plasma of recovered patients can be used to treat COVID-19. COVID-19: Effects in children Although originally thought to be harmless in children, there is increasing evidence that children are not completely invulnerable to COVID-19 First Previous 56 57 58 59 60 Next Last